23andMe Holding CoME

HealthcareBiotechnology

A direct-to-consumer genetic testing company that offers ancestry and health reports from saliva-based DNA kits. It also operates a therapeutics division that uses its genetic database for drug discovery. Investors track the stock for its consumer data moat and its volatile post-IPO history.

Congressional Interest in 23andMe Holding Co (ME)

2 members of Congress have disclosed 3 trades in 23andMe Holding Co (ME), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.